| Trial ID: | L0829 |
| Source ID: | NCT00005010
|
| Associated Drug: |
Irbesartan
|
| Title: |
Prevention of Kidney Transplant Rejection
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End-Stage Renal Disease|Chronic Allograft Nephropathy
|
| Interventions: |
DRUG: Irbesartan|DRUG: Pravastatin
|
| Outcome Measures: |
Primary: death, or renal failure manifested by initiation of dialysis or retransplantation., Randomization to End of Study |
|
| Sponsor/Collaborators: |
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
2004-03
|
| Results First Posted: |
|
| Last Update Posted: |
2013-01-25
|
| Locations: |
Ilene Blechman-Krom, Rockville, Maryland, 20850, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00005010
|
